Neuronetics (STIM) Research & Development (2017 - 2026)

Neuronetics (STIM) has 10 years of Research & Development data on file, last reported at $10.7 million in Q1 2026.

• On a quarterly basis, Research & Development rose 564.42% year-over-year to $10.7 million in Q1 2026; TTM through Mar 2026 was $56.6 million, a 155.93% increase from a year earlier, with the FY2025 full-year figure at $47.5 million, up 271.61% from the prior year.
• Research & Development for Q1 2026 stood at $10.7 million, down from $42.5 million in the prior quarter.
• Over the last five years, Research & Development for STIM reached as high as $42.5 million in Q4 2025 and fell as low as -$26.1 million in Q4 2023.
• Historically, Research & Development has averaged $6.7 million across 5 years, with a median of $3.1 million in 2022.
• Across the five-year window, Research & Development sank 931.06% in 2023 and jumped 637.01% in 2025, its largest moves.
• Year by year, Research & Development stood at $3.1 million in 2022, then sank by 931.06% to -$26.1 million in 2023, then jumped by 122.13% to $5.8 million in 2024, then soared by 637.01% to $42.5 million in 2025, then plunged by 74.76% to $10.7 million in 2026.
• Per Business Quant data, the three most recent Research & Development figures were $10.7 million in Q1 2026, $42.5 million in Q4 2025, and $1.5 million in Q3 2025.